2020 | Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children | 배승진 | Article |
2016 | FACTORS ASSOCIATED WITH POTENTIALLY INAPPROPRIATE MEDICATION USE IN ELDERLY KOREANS IN AN OUTPATIENT SETTING: A POPULATION-BASED STUDY | 배승진 | Letter |
2022 | How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea | 배승진 | Article |
2022 | Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version | 배승진 | Article |
2015 | Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea | 배승진 | Article |
2021 | The core composition of DNA block copolymer micelles dictates DNA hybridization properties, nuclease stabilities, and cellular uptake efficiencies | 이혁진; 박소정; 김찬진; 정은혜 | Article |
2016 | Eight-year experience of using HTA in drug reimbursement: South Korea | 배승진 | Article |
2013 | A cross-sectional study of factors related to gastrointestinal drug use in Korean adolescents | 곽혜선; 이병구; 이정연; 배승진 | Article |
2020 | Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? | 배승진 | Article |
2014 | Sourcing quality-of-life weights obtained from previous studies: Theory and reality in Korea | 배승진 | Review |